Lasofoxifene Modulation Of Membrane-Initiated Estrogen Signals And Methods For Tumor Treatment
Patent No. EP3568132 (titled "Lasofoxifene Modulation Of Membrane-Initiated Estrogen Signals And Methods For Tumor Treatment") was filed by Wang on Jan 10, 2017. The application was issued on Dec 3, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3568132
- Application Number
- EP17891267A
- Filing Date
- Jan 10, 2017
- Status
- Granted And Under Opposition
- Oct 31, 2025
- Publication Date
- Dec 3, 2025
- External Links
- Slate, Register , Google Patents